| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,439 |
7,576 |
$474K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,042 |
4,973 |
$420K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
637 |
539 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,801 |
1,529 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,333 |
849 |
$11K |
| 99215 |
Prolong outpt/office vis |
130 |
99 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,210 |
877 |
$8K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
30 |
30 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
31 |
26 |
$2K |
| 99173 |
|
345 |
297 |
$1K |
| 92551 |
|
292 |
247 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
16 |
14 |
$980.00 |
| 80305 |
|
72 |
62 |
$616.67 |
| 81003 |
|
280 |
237 |
$588.14 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
119 |
78 |
$450.28 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
323 |
259 |
$376.97 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
261 |
206 |
$112.58 |
| 81025 |
|
45 |
38 |
$110.99 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
12 |
$55.00 |
| 36415 |
Collection of venous blood by venipuncture |
32 |
30 |
$0.00 |